Selcen Öztürk
German Cancer Research Center(DE)Heidelberg University(DE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Immune Cell Function and Interaction, Cell death mechanisms and regulation, Glycosylation and Glycoproteins Research, CAR-T cell therapy research
Most-Cited Works
- → IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression(2020)550 cited
- → Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model(2012)190 cited
- → Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity(2021)118 cited
- → Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions(2012)109 cited
- → Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain(2015)77 cited
- → Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia(2017)55 cited
- → PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia(2018)55 cited
- → EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia(2021)52 cited
- → Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin(2018)39 cited
- → CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion(2019)19 cited